A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer

Applied Physiology, Nutrition and Metabolism

Volumn 37, Issue 5, 2012, Pages 811-821

  Di Sebastiano, Katie M ^a   Mourtzakis, Marina ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Advanced cancer; Air displacement plethysmography (ADP); Anthropometry; Bioelectrical impedance analysis (BIA); Breast cancer; Computed tomography (CT); Dual energy X ray absorptiometry (DXA); Magnetic resonance imaging (MRI); Prostate cancer

Indexed keywords

ADULT; ANTHROPOMETRY; BODY COMPOSITION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGY; PHOTON ABSORPTIOMETRY; PLETHYSMOGRAPHY; REVIEW; SKELETAL MUSCLE;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADULT; ANTHROPOMETRY; BODY COMPOSITION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; NEOPLASMS; PLETHYSMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865226189     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/H2012-079     Document Type: Review

References (81)

1. Aslani, A., Smith, R.C., Allen, B.J., Pavlakis, N., and Levi, J.A. 1999. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res. Treat. 57(3): 285-290. doi:10.1023/A:1006220510597. PMID:10617305.
2. Aslani, A., Smith, R.C., Allen, B.J., Pavlakis, N., and Levi, J.A. 2000. The predictive value of body protein for chemotherapy-induced toxicity. Cancer, 88(4): 796-803. doi:10.1002/(SICI)1097-0142 (20000215)88:4<796::AID-CNCR10>3.0.CO;2-P. PMID:10679649.
3. Bachmann, J., Heiligensetzer, M., Krakowski-Roosen, H., Buchler, M.W., Friess, H., and Martignoni, M.E. 2008. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J. Gastrointest. Surg. 12(7): 1193-1201. doi:10.1007/s11605-008-0505-z. PMID:18347879.
4. Balentine, C.J., Enriquez, J., Fisher, W., Hodges, S., Bansal, V., Sansgiry, S., et al. 2010. Intra-abdominal fat predicts survival in pancreatic cancer. J. Gastrointest. Surg. 14(11): 1832-1837. doi:10.1007/s11605-010-1297-5. PMID:20725799.
5. Baumgartner, R.N., Koehler, K.M., Gallagher, D., Romero, L., Heymsfield, S.B., Ross, R.R., et al. 1998. Epidemiology of Sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147(8): 755-763. doi:10.1093/oxfordjournals.aje.a009520. PMID: 9554417.
6. Beesley, V., Janda, M., Eakin, E., Obermair, A., and Battistutta, D. 2007. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive needs. Cancer, 109(12): 2607-2614. doi:10.1002/cncr.22684. PMID:17474128.
7. Biaggi, R.R., Vollman, M.W., Nies, M.A., Brener, C.E., Flakoll, P.J., Levenhagen, D.K., et al. 1999. Comparison of air-displacement plethysmography with hydrostatic weighing and bioelectrical impedance analysis for the assessment of body composition in healthy adults. Am. J. Clin. Nutr. 69(5): 898-903. PMID: 10232628.
8. Bourke, L., Thompson, G., Gibson, D.J., Daley, A., Crank, H., Adam, I., et al. 2011. Pragmatic lifestyle intervention in patients recovering from colon cancer: a randomized controlled pilot study. Arch. Phys. Med. Rehabil. 92(5): 749-755. doi:10.1016/j. apmr.2010.12.020. PMID:21530722.
9. Brown, T.T., Zelnik, D.L., and Dobs, A.S. 2003. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int. J. Gastrointest. Cancer, 34(2-3): 143-150. doi:10. 1385/IJGC:34:2-3:143. PMID:15361649.
10. Brozek, J., Grande, R., Anderson, J.T., and Keys, A. 1963. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann. N. Y. Acad. Sci. 110(1): 113-140. doi:10.1111/j.1749-6632.1963.tb17079.x. PMID:14062375.
11. Canadian Cancer Society's Steering Committee on Cancer Statistics. 2011. Canadian Cancer Statistics 2011. Canadian Cancer Society. Toronto, Ont., Canada.
12. Colomer, R., Moreno-Nogueira, J.M., Garcia-Luna, P.P., Garcia-Peris, P., Garcia de Lorenzo, A., Zarazaga, A., et al. 2007. n-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br. J. Nutr. 97(5): 823-831. doi:10.1017/S000711450765795X. PMID:17408522.
13. Demark-Wahnefried, W., Peterson, B.L., Winer, E.P., Marks, L., Aziz, N., Marcom, P.K., et al. 2001. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 19(9): 2381-2389. PMID:11331316.
14. Dewys, W.D., Begg, C., Lavin, P.T., Band, P.R., Bennett, J.M., Bertino, J.R., et al. Eastern Cooperative Oncology Group. 1980. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am. J. Med. 69(4): 491-497. doi:10.1016/S0149-2918(05)80001-3. PMID: 7424938.
15. Donohoe, C.L., Doyle, S.L., and Reynolds, J.V. 2011. Visceral adiposity, insulin resistance and cancer risk. Diabetol. Metab. Syndr. 3(1): 12. doi:10.1186/1758-5996-3-12. PMID:21696633.
16. Ellegård, L.H., Åhlén, M., Körner, U., Ludhold, K.G., Plank, L.D., and Bosaeus, I.G. 2009. Bioelectrical impedance spectroscopy underestimates fat-free mass compared to duel energy x-ray absorptiometry in incurable cancer patients. Eur. J. Clin. Nutr. 63(6): 794-801. doi:10.1038/ejcn.2008.35.
17. Ellis, K.J. 2001. Selected body composition methods can be used in field studies. J. Nutr. 131(5): 1589S-1595S. PMID:11340123.
18. Fearon, K., Strasser, F., Anker, S.D., Bosaeus, I., Bruera, E., Fainsinger, R.L., et al. 2011. Definition and classification of cancer cachexia: and international consensus. Lancet Oncol. 12(5): 489-495. doi:10.1016/S1470-2045(10)70218-7. PMID:21296615.
19. Freedman, R.J., Aziz, N., Albanes, D., Hartman, T., Danforth, D., Hill, S., et al. 2004. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J. Clin. Endocrinol. Metab. 89(5): 2248-2253. doi:10.1210/jc.2003-031874. PMID:15126549.
20. Fu, M.R., Ridner, S.H., and Armer, J. 2009. Post-breast cancer. Lymphedema: part 1. Am. J. Nurs. 109(7): 48-54, quiz 55. doi:10.1097/01.NAJ.0000357172.94131.58. PMID:19546644.
21. Genton, L., Hans, D., Kyle, U.G., and Pichard, C. 2002. Duel energy x-ray absorptiometry and body composition: differences between devices and comparison with reference methods. Nutrition, 18(1): 66-70. doi:10.1016/S0899-9007(01)00700-6.
22. Gray, D.S., Bray, G.A., Bauer, M., Kaplan, K., Gemayel, N., Wood, R., et al. 1990. Skinfold thickness measurement in obese subjects. Am. J. Clin. Nutr. 51(4): 571-577. PMID:2321565.
23. Harvie, M.N., Campbell, I.T., Baildam, A., and Howell, A. 2004. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res. Treat. 83(3): 201-210. doi:10. 1023/B:BREA.0000014037.48744.fa. PMID:14758090.
24. Haseen, F., Murray, L.J., Cardwell, C.R., O'Sullivan, J.M., and Cantwell, M.M. 2010. The effects of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J. Cancer Surviv. 4(2): 128-139. doi:10.1007/s11764-009-0114-1. PMID:20091248.
25. Heymsfield, S.B. 2008. Development of imaging methods to assess adiposity and metabolism. Int. J. Obes. (Lond.) 32(Suppl. 7): S76-S82. doi:10.1038/ijo.2008.242. PMID:19136995.
26. Heymsfield, S.B., Olafson, R.P., Kutner, M.H., and Nixon, D.W. 1979. A radiographic method of quantifying protein-calorie undernutrition. Am. J. Clin. Nutr. 32(3): 693-702. PMID:105625.
27. Heymsfield, S.B., Wang, Z., Baumgartner, R.N., and Ross, R. 1997. Human body composition: advances in models and methods. Annu. Rev. Nutr. 17: 527-558. doi:10.1146/annurev.nutr.17.1.527. PMID:9240939.
28. Hooning, M.J., Botma, A., Aleman, B.M., Baaijens, M.H., Bartelink, H., Klijn, J.G., et al. 2007. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J. Natl. Cancer Inst. 99(5): 365-375. doi:10.1093/jnci/djk064. PMID:17341728.
29. Imamoto, H., Oba, K., Sakamoto, J., Iishi, H., Narahara, H., Yumiba, T., et al. 2011. Assessing clinical benefit response in the treatment of gastric malignant ascites with nonmeasureable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer, 14(1): 81-90. doi:10.1007/s10120-011-0016-6. PMID:21327925.
30. Jackson, A.S., and Pollock, M.L. 1978. Generalized equations for predicting body density of men. Br. J. Nutr. 40(3): 497-504. doi:10.1079/BJN19780152. PMID:718832.
31. Jackson, A.S., Pollock, M.L., and Ward, A. 1980. Generalized equations for predicting body density of women. Med. Sci. Sports Exerc. 12(3): 175-181. PMID:7402053.
32. Johansen, D., Stocks, T., Jonsson, H., Lindkvist, B., Bjorge, T., Concin, H., et al. 2010. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580, 000 men and women in the metabolic syndrome and cancer project. Cancer Epidemiol. Biomarkers Prev. 19(9): 2307-2317. doi:10.1158/1055-9965.EPI-10-0234. PMID:20826833.
33. Johnson, J., and Dawson-Hughes, B. 1991. Precision and stability of dual-energy X-ray absorptiometry measurements. Calcif. Tissue Int. 49(3): 174-178. doi:10.1007/BF02556113. PMID:1933582.
34. Joshu, C.E., Mondul, A.M., Menke, A., Meinhold, C., Han, M., Humphreys, E.B., et al. 2011. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev. Res. (Phila.), 4(4): 544-551. doi:10. 1158/1940-6207.CAPR-10-0257. PMID:21325564.
35. Keating, N.L., O'Malley, A.J., and Smith, M.R. 2006. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J. Clin. Oncol. 24(27): 4448-4456. doi:10.1200/ JCO.2006.06.2497. PMID:16983113.
36. Keating, N.L., O'Malley, A.J., Freedland, S.J., and Smith, M.R. 2010. Diabetes and cardiovascular disease during androgen deprivations therapy: observational study of veterans with prostate cancer. J. Natl. Cancer Inst. 102(1): 39-46. doi:10.1093/jnci/ djp404. PMID:19996060.
37. Kubo, A., and Corley, D.A. 2006. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15(5): 872-878. doi:10.1158/1055-9965.EPI-05-0860. PMID: 16702363.
38. Kyle, U.G., Bosaeus, I., De Lorenzo, A.D., Deurenberg, P., Elia, M., Gómez, J.M., et al.; Composition of the ESPEN Working Group. 2004a. Bioelectrical impedance analysis - part I: review of principles and methods. Clin. Nutr. 23(5): 1226-1243. doi:10. 1016/j.clnu.2004.06.004. PMID:15380917.
39. Kyle, U.G., Bosaeus, I., De Lorenzo, A.D., Deurenberg, P., Elia, M., Gómez, J.M., et al.; Composition of the ESPEN Working Group. 2004b. Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin. Nutr. 23(6): 1430-1453. doi:10.1016/j.clnu. 2004.09.012. PMID:15556267.
40. Lee, S.Y., and Gallagher, D. 2008. Assessment methods of human body composition. Curr. Opin. Clin. Nutr. Metab. Care, 11(5): 566-572. doi:10.1097/MCO.0b013e32830b5f23. PMID: 18685451.
41. Levy, M.E., Perera, S., van Londen, G.J., Nelson, J.B., Clay, C.A., and Greenspan, S.L. 2008. Physical function changes in prostate cancer patients on androgen deprivation therapy; a 2-year prospective study. Urology, 71(4): 735-739. doi:10.1016/j. urology.2007.09.018. PMID:18279933.
42. Lieffers, J.R., Mourtzakis, M., Hall, K.D., McCargar, L.J., Prado, C.M., and Baracos, V.E. 2009. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am. J. Clin. Nutr. 89(4): 1173-1179. doi:10.3945/ajcn.2008.27273. PMID:19244378.
43. Ligibel, J.A., Campbell, N., Partridge, A., Chen, W.Y., Salinardi, T., Chen, H., et al. 2008. Impact of mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J. Clin. Oncol. 26(6): 907-912. doi:10.1200/JCO.2007.12.7357. PMID:18281663.
44. Lim, S., Kim, J.H., Yoon, J.W., Kang, S.M., Choi, S.H., Park, Y.J., et al. 2010. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care, 33(7): 1652-1654. doi:10. 2337/dc10-0107. PMID:20460442.
45. Lohman, T.G., Harris, M., Teixeira, P.J., and Weiss, L. 2000. Assessing body composition and changes in body composition: another look at duel energy x-ray absorptiometry. Ann. N. Y. Acad. Sci. 904(1): 45-54. doi:10.1111/j.1749-6632.2000.tb06420.x. PMID:10865709.
46. Lowrance, W.T., Elkin, E.B., Yee, D.S., Feifer, A., Ehdaie, B., Jacks, L.M., et al. 2012. Locally advanced prostate cancer: a populationbased study of treatment patterns. BJU Int. 109(9): 1309-1314. doi:10.1111/j.1464-410X.2011.10760.x. PMID:22085255.
47. Mattsson, S., and Thomas, B.J. 2006. Development of methods for body composition studies. Phys. Med. Biol. 51(13): R203-R228. doi:10.1088/0031-9155/51/13/R13. PMID:16790904.
48. McCrory, M.A., Gomez, T.D., Bernauer, E., and Molé, P.A. 1995. Evaluation of a new air displacement plethysmograph for measuring human body composition. Med. Sci. Sports Exerc. 27(12): 1686-1691. PMID:8614326.
49. Miller, K.D., Jones, E., Yanovski, J.A., Shankar, R., Feuerstein, I., and Falloon, J. 1998. Visceral abdominal-fat accumulation associated with use of indinvir. Lancet, 351(9106): 871-875. doi:10.1016/S0140-6736(97)11518-5. PMID:9525365.
50. Mitsiopoulos, N., Baumgartner, R.N., Heymsfield, S.B., Lyons, W., Gallagher, D., and Ross, R. 1998. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J. Appl. Physiol. 85(1): 115-122. PMID:9655763.
51. Morley, J.E. 2009. Calories and cachexia. Curr. Opin. Clin. Nutr. Metab. Care, 12(6): 607-610. doi:10.1097/MCO.0b013e328331e9ce. PMID:19741513.
52. Mourtzakis, M., Prado, C.M.M., Lieffers, J.R., Reiman, T., McCargar, L.J., and Baracos, V.E. 2008. A practical and precise approach to quantifications of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab. 33(5): 997-1006. doi:10.1139/H08-075. PMID:18923576.
53. Murphy, R.A., Wilke, M.S., Perrine, M., Pawlowicz, M., Mourtzakis, M., Lieffers, J.R., et al. 2010. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin. Nutr. 29(4): 482-487. doi:10.1016/j.clnu.2009.11. 006. PMID:19959263.
54. Murphy, R.A., Mourtzakis, M., Chu, Q.S., Baracos, V.E., Reiman, T., and Mazurak, V.C. 2011a. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer, 117(16): 3774-3780. doi:10. 1002/cncr.25933. PMID:21328326.
55. Murphy, R.A., Yeung, E., Mazurak, V.C., and Mourtzakis, M. 2011b. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer-cachexia. Br. J. Cancer, 105(10): 1469-1473. doi:10.1038/bjc.2011.391. PMID:21970879.
56. National Institutes of Health. 2008. Weight and waist measurement: tools for adults. Weight-control Information Network. NIH Publications no. 04-5283.
57. Nissen, M.J., Shapiro, A., and Swenson, K.K. 2011. Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin. Breast Cancer, 11(1): 52-60. PMID: 21421523.
58. Piccoli, A., Rossi, B., Pillon, L., and Bucciante, G. 1996. Body fluid overload and bioelectrical impedance analysis in renal patients. Miner. Electrolyte Metab. 22(1-3): 76-78. PMID:8676831.
59. Pietrobelli, A., Formica, C., Wang, Z., and Heymsfield, S.B. 1996. Duel-energy x-ray absorptiometry body composition model: review of physical concepts. Am. J. Physiol. 271(6): E941-E951. PMID:8997211.
60. Plank, L.D. 2005. Duel-energy X-ray absorptiometry and body composition. Curr. Opin. Clin. Nutr. Metab. Care, 8(3): 305-309. doi:10.1097/01.mco.0000165010.31826.3d. PMID:15809534.
61. Pouliot, M.C., Despres, J.P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., et al. 1994. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am. J. Cardiol. 73(7): 460-468. doi:10. 1016/0002-9149(94)90676-9. PMID:8141087.
62. Prado, C.M.M., Baracos, V.E., McCargar, L.J., Mourtzakis, M., Mulder, K.E., Reiman, T., et al. 2007. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin. Cancer Res. 13(11): 3264-3268. doi:10.1158/1078-0432.CCR-06-3067. PMID:17545532.
63. Rock, C.L., and Demark-Wahnefried, W. 2002. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J. Clin. Oncol. 20(15): 3302-3316. doi:10.1200/JCO.2002.03.008. PMID:12149305.
64. Saigal, C.S., Gore, J.L., Krupski, T.L., Hanley, J., Schonlau, M., and Litwin, M.S.Urologic Diseases in America Project. 2007. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer, 110(7): 1493-1500. doi:10.1002/ cncr.22933. PMID:17657815.
65. Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St Onge, M.P., Albu, J., et al. 2004a. Total body skeletal muscle and adipose tissue volumes; estimation from a single abdominal cross-sectional image. J. Appl. Physiol. 97(6): 2333-2338. doi:10.1152/ japplphysiol.00744.2004. PMID:15310748.
66. Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St Onge, M.P., Albu, J., et al. 2004b. Visceral adipose tissue relations between single-slice areas and total volume. Am. J. Clin. Nutr. 80(2): 271-278. PMID:15277145.
67. Siri, W.E. 1961. Body composition from fluid space and density. In Techniques for measuring by composition. Edited by J. Brozek and A. Henschel. National Academy of Science. Washington, D.C., USA. pp. 223-224.
68. Smith, M.R., Fuchs, V., Anderson, E.J., Fallon, M.A., and Manola, J. 2002. Measurement of body fat by dual-energy x-ray absorptiometry and bioimpedance analysis in med with prostate cancer. Nutrition, 18(7-8): 574-577. doi:10.1016/S0899-9007(02)00821-3.
69. Stephen, W.C., and Janssen, I. 2009. Sarcopenic obesity and cardiovascular disease risk in the elderly. J. Nutr. Health Aging, 13(5): 460-466. doi:10.1007/s12603-009-0084-z. PMID: 19390754.
70. Thibault, R., Cano, N., and Pichard, C. 2011. Quantification of lean tissue losses during cancer and HIV infections/AIDS. Curr. Opin. Clin. Nutr. Metab. Care, 14(3): 261-267. doi:10.1097/MCO. 0b013e3283455d60. PMID:21415734.
71. van Kreel, B.K., Cox-Reyven, N., and Soeters, P. 1998. Determination of total body water by multifrequency bio-electric impedance: development of several models. Med. Biol. Eng. Comput. 36(3): 337-345. doi:10.1007/BF02522480. PMID:9747574.
72. van Londen, G.J., Levy, M.E., Perera, S., Nelson, J.B., and Greenspan, S.L. 2008. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit. Rev. Oncol. Hematol. 68(2): 172-177. doi:10.1016/j.critrevonc.2008.06.006. PMID:18706829.
73. Viganó, M., Bruera, E., Jhangri, G.S., Newman, S.C., Fields, A.L., and Suarez-Almazor, M.E. 2000. Clinical survival predictors in patients with advanced cancer. Arch. Intern. Med. 160(6): 861-868. doi:10.1001/archinte.160.6.861. PMID:10737287.
74. von Hafe, P., Pina, F., Perez, A., Tavares, M., and Barros, H. 2004. Visceral fat accumulation as a risk factor for prostate cancer. Obes. Res. 12(12): 1930-1935. doi:10.1038/oby.2004.242. PMID: 15687393.
75. Walia, B.N., Bhalla, A.K., and Suri, S. 1992. Reliability of skinfold calipers as a tool of measuring body fat in human beings. Indian J. Med. Res. 96: 255-257. PMID:1428065.
76. WCRF and AICR. 2007. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. RR Donnelley, Washington, D.C., USA. pp. 210-228.
77. WHO. 2001. Obesity: preventing and managing the global epidemic. WHO technical report series 894. World Health Organization, Geneva, Switzerland.
78. WHO. 2008. Waist circumference and waist-hip ratio: report of a WHO expert consultation. World Health Organization, Geneva, Switzerland. pp. 8-11.
79. Wigmore, S.J., Plester, C.E., Richardson, R.A., and Fearon, K.C.H. 1997. Changes in nutritional status associated with unresectable pancreatic cancer. Br. J. Cancer, 75(1): 106-109. doi:10.1038/bjc. 1997.17. PMID:9000606.
80. Zilli, T., Nguyen, T.V., Bahary, J.P., Chagnon, M., Dufresne, A., and Taussky, D. 2011. Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediaterisk prostate cancer treated with radiotherapy. Int. J. Obes. (Lond.), 35(11): 1421-1426. doi:10.1038/ijo.2010.279. PMID:21266950.
81. Zimmet, P.Z., and Alberti, K.G. 2006. Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring), 14(1): 1-3. doi:10.1038/oby.2006.1. PMID:16493116.